Artificial intelligence in computed tomography for quantifying lung changes in the era of CFTR modulators

AI allows fully automated volumetric quantification of CF-related modifications over an entire lung. The novel scoring system could provide a robust disease outcome in the era of effective CF transmembrane conductance regulator modulator therapy.